SCHEMBL4976847

SCHEMBL4976847

O=C1N[C@]2(C(=O)Nc3ccc(F)cc32)C(=O)N1Cc1cc(C(F)(F)F)ccc1Cl

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRAP1 Q12931 3/20 0.39
HSP90AA1 P07900 1/20 0.37
HSP90B1 P14625 1/20 0.37
PTGDR2 Q9Y5Y4 4/20 0.37
P2RX7 Q99572 1/20 0.36
CRHR1 P34998 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.34
AKR1B1 P15121 3/20 0.34
CHRM5 P08912 1/20 0.34
CYP1A2 P05177 2/20 0.33
MAPT P10636 2/20 0.33
CYP2C19 P33261 2/20 0.33
KMT2A Q03164 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
AGTR1 P30556 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5135639 0.88 AKR1B1 (0.38) PTGDR2SMN1; SMN2AKR1B1CYP1A2MAPT
SCHEMBL4259693 0.83 AKR1B1 (0.41) TRAP1HSP90AA1HSP90B1PTGDR2P2RX7
SCHEMBL4976851 0.78 TRAP1 (0.39) TRAP1HSP90AA1HSP90B1P2RX7CRHR1
SCHEMBL3957230 0.76 ALDH1A1 (0.39) PTGDR2AKR1B1CYP1A2MAPTCYP2C19
SCHEMBL2486352 0.74 PTGDR2 (0.62) PTGDR2AKR1B1CYP2C9
SCHEMBL4262078 0.73 HSP90AA1 (0.39) TRAP1HSP90AA1HSP90B1PTGDR2P2RX7
SCHEMBL2484248 0.72 PTGDR2 (0.64) PTGDR2MAPTKMT2AMEN1ALDH1A1
SCHEMBL3950566 0.72 AKR1B1 (0.42) AKR1B1CYP1A2MAPTCYP2C19KMT2A
SCHEMBL4979296 0.72 AKR1B1 (0.41) SMN1; SMN2AKR1B1CYP1A2MAPTCYP2C19
SCHEMBL4263802 0.71 AKR1B1 (0.43) PTGDR2AKR1B1CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1984374-A1 USE OF SPIRO Ý IMIDAZOLIDINE-4, 3'-INDOLE¨2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 AstraZeneca AB (SE) 2008-10-29 EP disclosed
WO-2007091946-A1 USE OF SPIRO [ IMIDAZOLIDINE-4, 3'-INDOLE] 2, 2', 5' (1H) TRIONES FOR TREATMENT OF CONDITIONS ASSOCIATED WITH VANILLOID RECEPTOR 1 ASTRAZENECA AB (SE) 2007-08-16 WO disclosed